What is Palopegteriparatide?
The short answer
Palopegteriparatide is a peptide, a short chain of amino acids. In the US, you need a prescription to get Palopegteriparatide.
- 1 source
- Status as of
- How we source
- Ellum doesn't sell peptides.
Get updates on Palopegteriparatide
What it is
- Type
- Long-acting PTH(1-34) prodrug (peptide)
- Also known as
- yorvipath
- How it works
- Steady PTH replacement for hypoparathyroidism.
Regulatory status
FDA-approved (Rx) How we label status
As of October 4, 2026, Palopegteriparatide is an FDA-approved prescription drug for hypoparathyroidism in adults.
- Federal (FDA)
- Approved Rx (Yorvipath NDA216490, 2024)
- 503A compounding
- Approved-drug component (not in any 503A category) (as of May 14, 2026)
References
Sources as of October 4, 2026